OPEN END TURBO LONG - INSPIRE MEDICAL SYSTEMS Stock

Certificat

DE000ME290E0

Market Closed - Börse Stuttgart 15:56:53 2024-05-31 EDT
3 EUR +16.28% Intraday chart for OPEN END TURBO LONG - INSPIRE MEDICAL SYSTEMS
Current month-73.09%
1 month-73.09%
Date Price Change
24-05-31 3 +16.28%
24-05-30 2.58 -16.77%
24-05-29 3.1 +4.03%
24-05-28 2.98 -.--%
24-05-27 2.98 -1.00%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 03:56 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying INSPIRE MEDICAL SYSTEMS, INC.
Issuer Morgan Stanley
WKN ME290E
ISINDE000ME290E0
Date issued 2023-10-18
Strike 127.6 $
Maturity Unlimited
Parity 10 : 1
Emission price 2.99
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 11.97
Lowest since issue 0.88

Company Profile

Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire system is the FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The Company has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sell its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ENT physicians and sleep centers.
Sector
-
More about the company

Ratings for Inspire Medical Systems, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Inspire Medical Systems, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
158.8 USD
Average target price
250.7 USD
Spread / Average Target
+57.90%
Consensus